Pneumococcus has over 100 serotypes, with serotype 3 being particularly threatening. Most severe cases of pneumonia and hospitalizations in both children and adults are caused by serotype 3 pneumococcus.

Key Information:

• 15-Valent Pneumococcal Vaccine:
  • Approved by the FDA and the European Union.
  • Widely used in countries such as the USA, UK, Canada, and Australia.
• Coverage: Protects against 15 serotypes of pneumococcus (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, 33F).
• Preventable Diseases: Helps prevent pneumonia and invasive diseases, such as meningitis and septicemia.
• Eligibility: Suitable for infants aged 6 weeks and older.

Vaccination is essential for reducing the risk of serious pneumococcal infections.

This is the latest human papillomavirus vaccine available on the market, effectively preventing cervical cancer, vulvar cancer, vaginal cancer, anal cancer, and genital warts (cauliflower warts).